Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

H.U. Group Holdings

H.U.グループホールディングス

4544 · TSE · Services · 1 article

Financials Consolidated

Revenue¥247bn+1.8% year on yearConsolidated · FY3/26

Ordinary profit¥2.83bn−40.2% year on yearConsolidated · FY3/26

Net profit¥6.82bn+147.1% year on yearConsolidated · FY3/26

Dividend per share¥125.00FY3/26

Performance over time

Revenue
¥273bnFY3/22
¥261bnFY3/23
¥237bnFY3/24
¥243bnFY3/25
¥247bnFY3/26
Ordinary profit
¥47.4bnFY3/22
¥22.0bnFY3/23
−¥7.24bnFY3/24
¥4.74bnFY3/25
¥2.83bnFY3/26
Net profit (attributable)
¥29.6bnFY3/22
¥15.7bnFY3/23
−¥7.55bnFY3/24
¥2.76bnFY3/25
¥6.82bnFY3/26
Op. cash flow
¥55.2bnFY3/22
¥32.5bnFY3/23
¥16.6bnFY3/24
¥22.0bnFY3/25
¥21.6bnFY3/26

People & pay

Employees, whole group5,157 peopleFY3/26

Employees, parent company (non-consolidated)351 peopleFY3/26

Average salary¥8.10mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥247bn+1.8% year on year¥2.83bn¥6.82bn¥121.52¥125.00¥267bn¥137bn¥21.6bn
FY3/25¥243bn+2.6% year on year¥4.74bn¥2.76bn¥48.60¥125.00¥280bn¥137bn¥22.0bn
FY3/24¥237bn−9.2% year on year−¥7.24bn−¥7.55bn−¥132.77¥125.00¥291bn¥143bn¥16.6bn
FY3/23¥261bn−4.4% year on year¥22.01bn¥15.68bn¥275.52¥125.00¥298bn¥150bn¥32.5bn
FY3/22¥273bn¥47.42bn¥29.60bn¥519.55¥125.00¥287bn¥140bn¥55.2bn

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YB46 · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4544

  1. H.U. Group's Lab-Testing Unit Turns Profitable as Alzheimer's Test Clears Europe

    H.U. Group Holdings swung to a ¥1.57bn quarterly profit as price adjustments fixed its loss-making testing-services unit, while a blood-based Alzheimer's diagnostic won certification in Europe.

Buybacks

Authorised and executed under the company’s current programmes.

2 programmes · data through

The line marks how much of the buying window has passed; a bar beyond it is buying ahead of pace.

Buybacks
ResolutionProgress by companyFiling
Runs to 31 Mar 202798% of yen limit used¥4.92bn / ¥5bn · 1.45m / 2.5m shares43% of the buying window to 31 Mar 2027 has passedFiled  — filing S100Z78G
Runs to 31 Mar 2026100% of yen limit used¥5bn / ¥5bn · 1.35m / 2.5m shares100% of the buying window to 31 Mar 2026 has passedFiled  — filing S100XXVI

AGM votes

This season’s shareholder voting results.

1 meeting · data through

AGM votes
ProposalApprovalResultFiling
Amendment of articles
Original (Japanese)定款一部変更の件
99.40%Votes cast: 99.94%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 石川 剛生
98.20%Votes cast: 98.78%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 粟井 佐知子
83.70%Votes cast: 84.15%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 稲垣 浩二
89.20%Votes cast: 89.71%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 太田 威彦
99.20%Votes cast: 99.82%ApprovedFiled  — filing S100YCZ7
Show 6 more meetings (11 total)
AGM votes
ProposalApprovalResultFiling
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 白川 もえぎ
82.30%Votes cast: 82.83%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 新宅 祐太郎
89.10%Votes cast: 89.60%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 橋本 勝則
89.20%Votes cast: 89.68%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 松井 毅
99.20%Votes cast: 99.82%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 宮川 圭治
82.00%Votes cast: 82.50%ApprovedFiled  — filing S100YCZ7
Election of 10 directors
Original (Japanese)取締役10名選任の件
· 吉田 仁
83.30%Votes cast: 83.81%ApprovedFiled  — filing S100YCZ7

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.

Cross-holdings

Strategic shareholdings and sales, by fiscal year.

6 fiscal years · data through

Balance-sheet value
¥92mFY3/22
¥147mFY3/23
¥154mFY3/24
¥166mFY3/25
—FY3/26
Sale proceeds
¥136mFY3/22
¥0mFY3/23
—FY3/24
—FY3/25
¥283mFY3/26

Balance-sheet value is the reporting company's own listed holdings (its largest holding subsidiary's where marked), carried at market value; the percentage divides it by consolidated net assets in the same annual report.

Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 2026Largest holding subsidiary———1¥283mFiled  — filing S100YB46
Show 5 more fiscal years (6 total)
Cross-holdings
Fiscal year endHoldings (issuers)Balance-sheet value% of consolidated net assetsIssues cutSale proceedsFiling
31 Mar 2025Largest holding subsidiary1¥166m———Filed  — filing S100VXAH
31 Mar 20243¥154m0.11%——Filed  — filing S100TMPA
31 Mar 20233¥147m0.10%1¥0Filed  — filing S100QZI9
31 Mar 20223¥92m0.07%1¥136mFiled  — filing S100OATL
31 Mar 20214¥228m0.20%——Filed  — filing S100M4WA

Fund positioning

Current holdings disclosed by tracked funds.

25 funds · data through

Held by 25 tracked funds; largest weight 4.86%. Holdings as of 31 Jul 2026–10 Nov 2026.

Show 15 more funds (25 total)